Français English

Investors

Corporate Profile

Inventiva (Euronext Paris and Nasdaq: IVA) is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”) and other diseases with significant unmet medical needs.

Financial Information

Upcoming Events

  • First-Half 2026 Revenue and Cash Position July 29, 2026
  • First-Half 2026 Results September 25, 2026
  • Q3 2026 Revenue and Cash Position November 23, 2026
Financial Calendar

Nasdaq Share Information

IVA

Inventiva American Depositary Shares

Market: Nasdaq

Currency: USD

Symbol: IVA

Listing: ADS

View Nasdaq Quote

Euronext Share Information

IVA

Inventiva ordinary shares

Market: Euronext Paris

Currency: EUR

Symbol: IVA

ISIN: FR0013233012

View Euronext Quote

Investor Contacts